UK widens and simplifies flagship medtech R&D funding programme; adds another £13m
This article was originally published in Clinica
The UK National Institute for Health Research (NIHR) is to introduce two initiatives that will expand the scope and simplify the funding application process of flagship medtech R&D programme, Invention for Innovation (i4i). The initiatives will come into effect together with a new £13m ($21m) funding round being launched next week.
You may also be interested in...
Draft policy moots crowdfunding for high-cost rare diseases alongside financial support for those "amenable to one-time treatment" but falls way short of some patient groups' expectations.
India’s Hilleman Laboratories says it’s aiming to develop an affordable vaccine that will target pregnant women in low- and middle-income countries to prevent Group B Streptococcus, a potentially fatal infection passed to babies during childbirth.
Chi-Med’s surufatinib has come up trumps in a second trial in neuroendocrine tumors, after the monitoring committee recommended an early halt following achievement of its PFS target in the pancreatic setting.